IP Archives of Cytology and Histopathology Research

Print ISSN: 2581-5725

Online ISSN: 2456-9267

CODEN : IACHCL

IP Archives of Cytology and Histopathology Research (ACHR) open access, peer-reviewed quarterly journal publishing since 2016 and is published under the Khyati Education and Research Foundation (KERF), is registered as a non-profit society (under the society registration act, 1860), Government of India with the vision of various accredited vocational courses in healthcare, education, paramedical, yoga, publication, teaching and research activity, with the aim of faster and better dissemination of knowledge, we will be publishing the article more...

Article type

Case Report


Article page

57-59


Authors Details

Amritha Malini*, Fady Hachem, Hiran Ravindran


Article Metrics


View Article As

 


Downlaod Files

   






Article statistics

Viewed: 373

PDF Downloaded: 216


Vulval fibroadenoma, a common tumor at an uncommon site - A case report with review of literature


Case Report

Author Details : Amritha Malini*, Fady Hachem, Hiran Ravindran

Volume : 7, Issue : 1, Year : 2022

Article Page : 57-59

https://doi.org/10.18231/j.achr.2022.011



Suggest article by email

Get Permission

Abstract

Vulval fibroadenoma is a rare benign tumour arising from anogenital mammary like glands. Vulva is an uncommon site for fibroadenoma. This is a case of 33 year old female presented with well defined mass in the right labia majora with a histopathological diagnosis of Vulval fibroadenoma confirming origin from ectopic breast tissue.
 

Keywords: Ectopic breast tissue, Mass vulva, Fibroadenoma


How to cite : Malini A, Hachem F, Ravindran H, Vulval fibroadenoma, a common tumor at an uncommon site - A case report with review of literature. IP Arch Cytol Histopathol Res 2022;7(1):57-59

This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.